TABLE 4.
Median of differences in inflammatory markers' levels (1 Yr – T0) between control and diseased groups
| Control | Diseased | p‐Value | |
|---|---|---|---|
|
Median (Min–Max) |
Median (Min–Max) |
||
| FGF‐23 |
9.73 (−84.85–43.30) |
−23.25 (−2290.83–0.75) |
<.001*** |
| IL‐1β |
12.27 (−2.94–29.86) |
2.33 (−21.81–23.05) |
<.001*** |
| IL‐8 |
13.20 (−53.86–30.68) |
1.81 (−60.01–43.26) |
.018* |
| Pentraxin 3 |
−712.95 (−4423.19–848.30) |
−506.44 (−5713.71–3045.42) |
.842 |
| TNF‐α |
6.58 (−4.55–19.66) |
−2.40 (−56.28–6.68) |
<.001*** |
| ICAM‐1 |
157298.40 (−15679.31–744264.41) |
−7930.73 (−309938.38–565303.47) |
.001** |
| IL‐6 |
0.70 (−3.66–9.87) |
0.13 (−43.56–58.50) |
.066 |
| MMP‐8 |
70.92 (−10128.77–8016.13) |
95.33 (−11193.18–6584.93) |
.850 |
| E‐Selectin |
11115.80 (−16010.17–80732.12) |
−3784.97 (−25636.14–25294.13) |
.001** |
| VCAM‐1 |
132848.12 (−586423.55–1621437.33) |
−124444.23 (−920491.86–287123.56) |
.034* |
| hs‐CRP |
34698.61 (−4064.71–109538.16) |
8421.95 (−334896.38–95955.55) |
.013* |
| MMP‐2 |
13046.33 (525.72–21849.70) |
14494.33 (−9878.80–31734.41) |
.491 |
| MMP‐9 |
2561.71 (−23992.76–28933.22) |
3025.84 (−39642.44–39106.00) |
.861 |
| C3 |
−111.26 (−1317.21–314.15) |
41.33 (−1024.83–1144.36) |
.179 |
| ADMA |
−2738.97 (−5206.02–3112.71) |
−5142.16 (−604309.77–2051.32) |
.008** |
Note: The values are given as Median (Minimum–Maximum); p Value—Difference between Median of Control and Disease group using Mann–Whitney test; *(p < .05); **(p < .01); ***(p < .001), ****(p < .0001).